Validation of the Eighth Edition TNM Lung Cancer Staging System-Reference-Cited by-同舟云学术

Validation of the Eighth Edition TNM Lung Cancer Staging System

Published:2020-04 Issue:4 Volume:15 Page:649-654
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hwang Joseph K.,Page Barbara J.^ORCID,Flynn David,Passmore Linda,McCaul Elizabeth,Brady Jaccalyne,Yang Ian A.,Marshall Henry,Windsor Morgan,Bowman Rayleen V.,Naidoo Rishendran,Guan Tracey,Philpot Shoni,Blake Michael E.,Fong Kwun M.

Funder

University of Queensland

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

2. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Groome;J Thorac Oncol,2007

3. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer;Postmus;J Thorac Oncol,2007

4. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer;Rami-Porta;J Thorac Oncol,2007

5. The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer;Rusch;J Thorac Oncol,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer;Cancer Treatment Reviews;2024-09

2. Exploring the discrepancies between clinical trials and real‐world data: A small‐cell lung cancer study;Clinical and Translational Science;2024-08

3. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer;Trends in Cancer;2024-07

4. Real‑world evidence of advanced non‑small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapy;Oncology Letters;2024-06-27

5. Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer;Frontiers in Oncology;2024-06-24